Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prognostic Value of Cardiac and Renal Markers in the Acute Phase of Ischemic Stroke or Transient Ischemic Attack :Albuminuria-Brain Natriuretic Peptide-Cystatine C in Stroke

NCT00479518 is registered in ClinicalTrials.gov with University Hospital, Tours as lead sponsor.

NCT NCT00479518
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00479518 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prognostic Value of Cardiac and Renal Markers in the Acute Phase of Ischemic Stroke or Transient Ischemic Attack :Albuminuria-Brain Natriuretic Peptide-Cystatine C in Stroke
Lead sponsor
University Hospital, Tours
Phase
Observational
Overall status
Completed
Start date
March 31, 2007
Completion date
February 28, 2017
Enrollment
159 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

ischemic stroke, transient ischemic attack